Company: INKT
Filing Date: 2025-06-18
Form Type: 8-K
Source: 0000950170-25-087888
Chunk: 0

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-06-18
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Stockholders (the “ Annual Meeting”) on June 18, 2025. A total of 2,793,022 shares of common stock, representing 70.41% of the shares outstanding and eligible to vote and constituting a quorum, were present at the Annual Meeting or represented by valid proxies. At the Annual Meeting, the Company’s stockholders voted on the following matters, which are described in detail in the Company’s Definitive Proxy Statement filed with the U. S. Securities and Exchange Commission on April 30, 2025: (i) to elect Jennifer Buell and Ulf Wiinberg as Class I directors, each for a term of three years expiring at the 2028 Annual Meeting of Stockholders (“ Proposal 1”), (ii) to approve the option exchange proposal (“ Proposal 2”), and (iii) to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 (“ Proposal 3”).

The Company’s stockholders elected each of the Class I director nominees nominated for election in Proposal 1 at the Annual Meeting. The Company’s stockholders voted for the Class I directors as follows:

  Class I Director Nominees            For      Against      Withheld      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────────────────────
  Jennifer Buell                 2,337,073            0        31,146               424,803  
  Ulf Wiinberg                   2,312,077            0        56,142               424,803  

The Company’s stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows:

        For      Against      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────
  2,269,364       97,538        1,317               424,803  

The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows:

        For      Against      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────
  2,773,188       12,846        6,988                     0  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act